(A. Kotok)
The French pharmaceutical company Sanofi-aventis said today it will take part in a program at the University of California, San Francisco (UCSF) that encourages innovative biomedical research. Sanofi-aventis will be the first industry partner in UCSF’s Program for Breakthrough Biomedical Research that awards funding to projects of potentially high impact and greater creativity.
Sanofi-aventis will fund up to five grants a year, with additional funds available for students or fellows to intern at Sanofi-aventis to conduct collaborative research. A joint UCSF/Sanofi-aventis committee will choose from among UCSF-generated proposals for their scientific excellence.
To further the exchange of ideas, Sanofi-aventis will fund an annual research forum of Sanofi-aventis and UCSF researchers on relevant scientific matters and to review progress of research projects funded through the collaboration.
Sanofi-aventis will also take part in a second collaboration with UCSF, an oncology collaboration to accelerate the progression of research through the clinical proof of concept stage.
Read more: Pfizer and UCSF Sign R&D Collaboration, More Planned
* * *
RSS - Posts
[…] Read more: Sanofi-Aventis to Support UCSF Research Program […]
[…] other collaborations with UCSF, on brain trauma and oncology research, started after becoming an industry partner of the university in January […]